Murdock Hunter R.
SEC insider (Form 3/4/5 filer). CIK 0001934008. General Counsel at Axsome Therapeutics, Inc. (AXSM). 15 reported Form 4/5 transactions since Sep 2024; latest on Apr 21, 2026. Located in NEW YORK, NY.
Companies Murdock Hunter R. has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Officer, General Counsel
Murdock Hunter R.
CIK: 0001934008
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axsome Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Apr 21, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectPerformance Stock Units
7.2K shares- - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
16.4K shares- - Jun 23, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect6K shares at avg. $100.12$602K - Jun 23, 2025AXSM
Axsome Therapeutics, Inc.
ExerciseDirect6K shares at avg. $29.91$180K - Jun 20, 2025AXSM
Axsome Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $29.91$224K - Jun 20, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect7.5K shares at avg. $102.47$769K - Jun 18, 2025AXSM
Axsome Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $29.91$224K - Jun 18, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect7.5K shares at avg. $100.90$757K - Jun 17, 2025AXSM
Axsome Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $29.91$224K - Jun 17, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect7.5K shares at avg. $100.26$752K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 21, 2026 | AXSM Axsome Therapeutics, Inc. | Award Performance Stock Units | 7,224 | - | - | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 16,385 | - | - | Direct |
| Jun 23, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 6,014 | $100.12 | $602,122 | Direct |
| Jun 23, 2025 | AXSM Axsome Therapeutics, Inc. | Exercise | 6,014 | $29.91 | $179,879 | Direct |
| Jun 20, 2025 | AXSM Axsome Therapeutics, Inc. | Exercise | 7,500 | $29.91 | $224,325 | Direct |
| Jun 20, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 7,500 | $102.47 | $768,525 | Direct |
| Jun 18, 2025 | AXSM Axsome Therapeutics, Inc. | Exercise | 7,500 | $29.91 | $224,325 | Direct |
| Jun 18, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 7,500 | $100.90 | $756,750 | Direct |
| Jun 17, 2025 | AXSM Axsome Therapeutics, Inc. | Exercise | 7,500 | $29.91 | $224,325 | Direct |
| Jun 17, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 7,500 | $100.26 | $751,950 | Direct |
1-10 of 15 transactions